Hochschulschrift
Characterization of Endogenous Major Histocompatibility Complex Class II Antigen Processing Pathways for Modified Vaccinia Virus Ankara Infection
- Weitere Titel
-
Charakterisierung der endogenen MHC (Major Histocompatibility Complex)-Klasse II-abhängigen Antigenprozessierungswege nach Infektion mit Modifiziertem Vaccinia Virus Ankara
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Technische Universität München, Diss., 2014
- Klassifikation
-
Biowissenschaften, Biologie
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der TU München
- (wann)
-
2014
- Urheber
-
Yi, Zhang
- Beteiligte Personen und Organisationen
-
Drexler, Ingo
Janssen, Klaus-Peter
Krug, Anne
- URN
-
urn:nbn:de:bvb:91-diss-20140220-1183526-0-7
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Yi, Zhang
- Drexler, Ingo
- Janssen, Klaus-Peter
- Krug, Anne
- Universitätsbibliothek der TU München
Entstanden
- 2014
Ähnliche Objekte (12)
Assembly of histocompatibility antigens
Identification of minor histocompatibility antigens
Identification of minor histocompatibility antigens
Antigene des Vaccinia Virus
Vaccinia-Antigen bei cutanem Erythematodes
Structure and biosynthesis of histocompatibility antigens (H-2, HLA)
Characterization of recombinant modified vaccinia virus Ankara for delivery of Middle East respiratory syndrome coronavirus spike protein antigens
Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens
Repair of the Vaccinia virus genes B2R and B3R inhibits interferon production uponmodified Vaccinia virus Ankara infection
Identification of classical minor histocompatibility antigen as cell-derived peptide
Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens
Functional characterization of modified vaccinia virus Ankara-encoded anti-apoptotic proteins
Assembly of histocompatibility antigens
Identification of minor histocompatibility antigens
Identification of minor histocompatibility antigens
Antigene des Vaccinia Virus
Vaccinia-Antigen bei cutanem Erythematodes
Structure and biosynthesis of histocompatibility antigens (H-2, HLA)
Characterization of recombinant modified vaccinia virus Ankara for delivery of Middle East respiratory syndrome coronavirus spike protein antigens
Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens
Repair of the Vaccinia virus genes B2R and B3R inhibits interferon production uponmodified Vaccinia virus Ankara infection
Identification of classical minor histocompatibility antigen as cell-derived peptide
Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens
Functional characterization of modified vaccinia virus Ankara-encoded anti-apoptotic proteins
Assembly of histocompatibility antigens
Identification of minor histocompatibility antigens
Identification of minor histocompatibility antigens
Antigene des Vaccinia Virus
Vaccinia-Antigen bei cutanem Erythematodes
Structure and biosynthesis of histocompatibility antigens (H-2, HLA)
Characterization of recombinant modified vaccinia virus Ankara for delivery of Middle East respiratory syndrome coronavirus spike protein antigens
Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens
Repair of the Vaccinia virus genes B2R and B3R inhibits interferon production uponmodified Vaccinia virus Ankara infection
Identification of classical minor histocompatibility antigen as cell-derived peptide
Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens